Vera Zhivotova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Vera Zhivotova has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Daria Ogneva
Fomin Clinic, Moscow 119192, Russia
1 shared publication - Elena Aleksandrovna Dunaeva
Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
1 shared publication - Irina Gaponova
Central Research Institute of Epidemiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing of Russian Federation, Moscow 111123, Russia
1 shared publication - Konstantin Olegovich Mironov
Central Research Institute of Epidemiology
1 shared publication - Tatiana Rumyantseva
Fomin Clinic, Moscow 119192, Russia
1 shared publication - Vasiliy Gennadievich Akimkin
Central Research Institute of Epidemiology, 111123 Moscow, Russia
1 shared publication
Latest Publications
- Open Access
- 5 June 2025
- Published by MDPI AG in Epigenomes
- Vol. 9 (2) , 19
Association of Model-Predicted Epigenetic Age and Female Infertility
Background: To date, there are no precise clinical and laboratory methods to accurately predict the onset of fertility decline in women, with chronological age being the ultimate predictor. This has led to increased interest in developing methods to determine biological age, as it provides a more accurate understanding of individual age-related physiological changes. Methods: In this study, we developed a model for estimating biological age based on DNA methylation levels in the ELOVL2, TRIM59, C1orf132, FHL2, and KLF14 genes using pyrosequencing. The model was tested in 64 Russian women, aged 25–39 years, to find an association between epigenetic age, infertility, low anti-Müllerian hormone (AMH) levels, and assisted reproductive technology (ART) failure. Results: The predictive performance of the model was evaluated. The mean absolute deviation of the model was 2.8 years; the mean absolute error was 2.6 years (R2 = 0.95). In the studied cohort, 33% of women exhibited epigenetic age acceleration (EAA), while 45% showed epigenetic age deceleration (EAD). All women with an EAA of ≥3 years (n = 6) had a history of infertility. Conclusions: In this study, no statistically significant associations were observed between EAA/EAD and AMH, body mass index, infertility, or ART failure in women.
- 5 June 2025
- Published by MDPI AG in Epigenomes
- Vol. 9 (2) , 19
Open AccessAssociation of Model-Predicted Epigenetic Age and Female Infertility
Background: To date, there are no precise clinical and laboratory methods to accurately predict the onset of fertility decline in women, with chronological age being the ultimate predictor. This has led to increased interest in developing methods to determine biological age, as it provides a more accurate understanding of individual age-related physiological changes. Methods: In this study, we developed a model for estimating biological age based on DNA methylation levels in the ELOVL2, TRIM59, C1orf132, FHL2, and KLF14 genes using pyrosequencing. The model was tested in 64 Russian women, aged 25–39 years, to find an association between epigenetic age, infertility, low anti-Müllerian hormone (AMH) levels, and assisted reproductive technology (ART) failure. Results: The predictive performance of the model was evaluated. The mean absolute deviation of the model was 2.8 years; the mean absolute error was 2.6 years (R2 = 0.95). In the studied cohort, 33% of women exhibited epigenetic age acceleration (EAA), while 45% showed epigenetic age deceleration (EAD). All women with an EAA of ≥3 years (n = 6) had a history of infertility. Conclusions: In this study, no statistically significant associations were observed between EAA/EAD and AMH, body mass index, infertility, or ART failure in women.